Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Additional common ingredients included phenoxyethanol (67.2%), tocopherol (65.7%), and sorbic acid derivatives (56.1%)
Serious risks can include pancreatitis, gallbladder disease, and kidney injury, and these medications carry a boxed warning for the risk of thyroid C-cell tumors
This peptide is seldomly sold by itself due to its less than impressive ability to increase growth hormone levels on its own
However, if you feel persistently dizzy, faint, or unusually weak during GLP-1 therapy, notify your healthcare provider immediately
Mounjaro (Tirzepatide) Dual action: targets both GLP-1 and GIP receptors Strong appetite suppression & improved blood sugar control Clinical trials show average body weight loss up to 22.5% over 72 weeks Wegovy (Semaglutide) Targets GLP-1 receptors only Licensed in the UK for obesity and cardiovascular protection STEP trials show 1521% body weight loss A new 7.2mg dose is expected in late 2025, with results potentially matching Mounjaro Both treatments are once-weekly injections, prescribed alongside healthy diet and lifestyle changes
-Ethan Lazarus, MD, FOMA
US$ 29.32
US$ 28.08
US$ 28.28
US$ 24.27
US$ 29.05
